Figure 1From: Development of the multi-attribute Adolescent Health Utility Measure (AHUM)AHUM Utilities Assigned to Pivotal & Extension Idursulfase Trial (Weeks 0 to 157): Perspective of UK Population. *p < 0.03 for treatment group differences in mean average utility at weeks 18, 36, & 53.Back to article page